Article Text

PDF
Randomised controlled trial
Low-molecular-weight heparin offers no benefit to patients with unexplained recurrent miscarriage in future pregnancy
  1. Katie Field
  1. Department of Obstetrics and Gynaecology, Trintiy College Dublin, St James Hospital, Dublin, Ireland
  1. Correspondence to : Dr Katie Field, Department of Obstetrics and Gynaecology, Trintiy College Dublin, St James Hospital, Dublin 8, Ireland; fieldk{at}tcd.ie

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMed.

Context

Recurrent miscarriage (RM) has been shown to affect between 1% and–3% of couples trying to conceive and up to 5% of those with two consecutive miscarriages are included. While there are many known risk factors for RM no underlying cause is found in nearly 50% of couples.1 The treatment of RM is usually aimed at the cause, which leaves us with very little to offer those with RM of unknown aetiology, and to date most of the treatment offered is …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.